# BLS Labs, LLC – FDA Inspection, Feb 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/bls-labs-llc/7eb4579e-5156-480b-b8fb-d44d6f7b5610
Source feed: FDA_Inspections

> FDA inspection 1229004 of BLS Labs, LLC, February 09, 2024. Classification: Voluntary Action Indicated (VAI). 16 citations under 21 CFR parts 211 and 1271. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229004
- Company Name: BLS Labs, LLC
- Inspection Date: 2024-02-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 16

## Related Documents

- [FDA Inspection 1152160 - 2021-09-03](https://www.keypedia.com/records/fda_inspections/bls-labs-llc/f7ecefba-945a-401b-8d38-214024906b68)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)
- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/bls-labs-llc/96a49dca-73cf-4aa8-8443-bcfb55458d28

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
